- 专利标题： Double-stranded RNA molecule targeting CKIP-1 and use thereof
-
申请号： US17474396申请日： 2021-09-14
-
公开(公告)号： US11939578B2公开(公告)日： 2024-03-26
- 发明人: Yanping Zhao , Hongjun Wang , Yuanyuan Jiang , Weiting Zhong , Jianmei Pang , Gong Li , Xiang Li , Yixin He , Liying Zhou , Yanan Liu
- 申请人： BEIJING TIDE PHARMACEUTICAL CO., LTD.
- 申请人地址： CN Beijing
- 专利权人： BEIJING TIDE PHARMACEUTICAL CO., LTD.
- 当前专利权人： BEIJING TIDE PHARMACEUTICAL CO., LTD.
- 当前专利权人地址： CN Beijing
- 代理机构： Baker, Donelson, Bearman, Caldwell & Berkowitz PC
- 代理商 Robin L. Teskin
- 优先权： WO TCN2017100863 2017.09.07 WO TCN2017100864 2017.09.07 WO TCN2017100865 2017.09.07 WO TCN2017100866 2017.09.07 WO TCN2017100867 2017.09.07
- 分案原申请号： US16644977
- 主分类号： C07H21/04
- IPC分类号： C07H21/04 ; A61P19/02 ; A61P19/08 ; A61P29/00 ; C12N15/113 ; C12N15/85 ; A61K48/00
摘要：
The present invention relates to the field of biomedicine, particularly to double-stranded RNA molecules targeting CKIP-1 and uses thereof, particularly to use of the double-stranded RNA molecules for the treatment of inflammatory diseases such as arthritis, particularly rheumatoid arthritis.
公开/授权文献
信息查询
